购物车
- 全部删除
- 您的购物车当前为空
Lusutrombopag (Mulpleta) 是一种口服生物可利用的小分子血小板生成素 (TPO) 受体激动剂,用于选择性侵入性手术前患有血小板减少症的慢性肝病的患者。
Lusutrombopag (Mulpleta) 是一种口服生物可利用的小分子血小板生成素 (TPO) 受体激动剂,用于选择性侵入性手术前患有血小板减少症的慢性肝病的患者。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 627 | 现货 | |
2 mg | ¥ 919 | 现货 | |
5 mg | ¥ 1,530 | 现货 | |
10 mg | ¥ 2,430 | 现货 | |
25 mg | ¥ 4,150 | 现货 | |
50 mg | ¥ 5,920 | 现货 | |
100 mg | ¥ 8,180 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 1,960 | 现货 |
产品描述 | Lusutrombopag (Mulpleta) is an orally bioavailable, small molecule thrombopoietin (TPO) receptor agonist for chronic liver disease (CLD) patients with thrombocytopenia prior to elective invasive surgery. |
体外活性 | Lusutrombopag is an agonist of the thrombopoietin receptor that activates platelet production. Lusutrombopag acts selectively on the human TPO receptor and activates signal transduction pathways that promote the proliferation and differentiation of bone marrow cells into megakaryocytes, thereby increasing platelet levels. |
别名 | 鲁索曲波帕, 芦曲泊帕, S-888711, Mulpleta |
分子量 | 591.55 |
分子式 | C29H32Cl2N2O5S |
CAS No. | 1110766-97-6 |
Smiles | CCCCCCO[C@@H](C)c1cccc(-c2csc(NC(=O)c3cc(Cl)c(\C=C(/C)C(O)=O)c(Cl)c3)n2)c1OC |
密度 | 1.299 g/cm3 (Predicted) |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 30 mg/mL (50.72 mM) | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容